Equasens: growth of 8.8% in 2022







Photo credit © ChaunuPictures


(Boursier.com) — On a like-for-like basis, 2022 sales of Equasens is
increase of 8.82% to 210.09 ME.

The group confirms the efficiency of its interoperability strategy between healthcare professionals and establishments with the identified challenge of structuring the healthcare offer, improving the coordination of healthcare players and the exchange of data around the patient.

Equasens maintains its ambitions for expansion in Europe in 2023, following the example of the strengthening of positions in the United Kingdom and Germany and development in other areas of health…


©2023 Boursier.com






Source link -87